WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.
复制标题
DOI:
10.1016/j.ccr.2011.10.016
复制
发表时间:
2011-12-13
期刊:
影响因子:
50.3
通讯作者:
Ladomery MR
中科院分区:
文献类型:
--
作者:
Amin EM;Oltean S;Hua J;Gammons MV;Hamdollah-Zadeh M;Welsh GI;Cheung MK;Ni L;Kase S;Rennel ES;Symonds KE;Nowak DG;Royer-Pokora B;Saleem MA;Hagiwara M;Schumacher VA;Harper SJ;Hinton DR;Bates DO;Ladomery MR
Angiogenesis is regulated by the balance of pro-angiogenic VEGF165 and anti-angiogenic VEGF165b splice isoforms. Mutations in WT1, the Wilms’ tumour suppressor gene, suppress VEGF165b and cause abnormal gonadogenesis, renal failure and Wilms’ tumours. In WT1 mutant cells, reduced VEGF165b was due to lack of WT1 mediated transcriptional repression of the splicing factor kinase SRPK1. WT1 bound to the SRPK1 promoter, and repressed expression through a specific WT1 binding-site. In WT1 mutant cells SRPK1-mediated hyperphosphorylation of the oncogenic RNA binding protein SRSF1 regulated splicing of VEGF, and rendered WT1 mutant cells pro-angiogenic. Altered VEGF splicing was reversed by wildtype WT1, knockdown of SRSF1 or SRPK1 and inhibition of SRPK1, which prevented in vitro and in vivo angiogenesis and associated tumour growth.
登录
查看更多内容
影响因子:
3.6
作者:
Artac, Robin A.;McFee, Renee M.;Cupp, Andrea S.
通讯作者:
Cupp, Andrea S.
影响因子:
4.4
作者:
Hua J;Spee C;Kase S;Rennel ES;Magnussen AL;Qiu Y;Varey A;Dhayade S;Churchill AJ;Harper SJ;Bates DO;Hinton DR
通讯作者:
Hinton DR
影响因子:
3.2
作者:
Krishnakumar, Subramanian;Mohan, Adithi;Das, Radha R.
通讯作者:
Das, Radha R.
影响因子:
5.1
作者:
DRASH, A;SHERMAN, F;BLIZZARD, RM
通讯作者:
BLIZZARD, RM
影响因子:
16
作者:
Bonnal, Sophie;Martinez, Concepcion;Valcarcel, Juan
通讯作者:
Valcarcel, Juan